First Look: 8 rapid fire presentations on Mass General Brigham’s new GCT technologies
Monday, May 2, 2022
New Gene and Cell Therapy technologies
- Moderators:
-
- Meredith Fisher, PhD
-
- Partner, Mass General Brigham Ventures
- Roger Kitterman
-
- VP, Mass General Brigham Ventures
- Presenters:
-
- Bakhos Tannous, PhD
-
- Director, Experimental Therapeutics Unit, Director, Viral Vector Core, MGH
- Professor of Neurology, HMS
- Vijaya Ramesh, PhD
-
- Co-Director of Neuroscience, Associate Geneticist in Neurology, MGH
- Professor of Neurology, HMS
- Anna Krichevsky, PhD
-
- Associate Professor of Neurology, BWH, HMS
- Nerea Zabaleta, PhD
-
- Principal Investigator, Grousbeck Gene Therapy Center, Mass Eye and Ear
- Instructor in Ophthalmology, HMS
- Francisco Quintana, PhD
-
- Professor, Neurology, Ann Romney Center for Neurologic Diseases, BWH
- Kuchroo Weiner Distinguished Professor of Neuroimmunology, BWH
- Stephen Haggarty, PhD
-
- Director, Chemical Neurobiology Laboratory, Center for Genomic Medicine, MGH
- Associate Professor of Neurology, HMS
- Michael Young, PhD
-
- Director, Minda de Gunzburg Center for Retinal Regeneration, Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear
- Associate Professor of Ophthalmology, Co-Director, Ocular Regenerative Medicine Institute, HMS
- Max Jan, MD, PhD
-
- Principal Investigator, Center for Cancer Research, MGH
- Assistant Professor of Pathology, HMS